WTX-26742-25655 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Registered in v-safe
2021-03-06
Dose 1 — Pfizer-BioNTech
2021-03-27
Dose 2 — Pfizer-BioNTech
2021-09-25
Survey response — 6 months, dose 2
MedDRA: Delivery, Nasopharyngitis, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Cold, preeclampsia & had a baby

MedDRA releases: 2024-11 · check-in free text available
2021-09-25
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2021-09-28
Call 1 — Left Voicemail
2022-03-27
Survey response — 12 months, dose 2
MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Fair

Free text: Increase in allergy symptoms

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Pfizer-BioNTech	No
2	2021-03-27	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-09-25	Unsuccessful

Free text

Release 9 — 6 months, dose 2

2021-09-25

Symptoms: Cold, preeclampsia & had a baby

Release 11 — 12 months, dose 2

2022-03-27

Symptoms: Increase in allergy symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Delivery	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Pre-existing disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release